High-dose psilocybin shows promise for depression treatment

Researchers compare the effectiveness and acceptability of oral monotherapy with psychedelics for the treatment of depressive symptoms.

‘A catalyst for revolution’: Launch of Thrive looks to safeguard public health

Brisbane is positioned to become the global hub for healthy buildings with today’s launch of the ARC Training Centre for Advanced Building Systems against Airborne

July 23, 2024

Novartis sues FDA over approval of Entresto generic, following rejection of petition

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 2, 2024

Elotuzumab Misses Mark Again as Frontline Treatment for Multiple Myeloma

Elotuzumab (Empliciti) failed for a third time to improve progression-free survival (PFS) in newly diagnosed multiple myeloma when added to standard therapy, a large randomized

February 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.